DoubleTwist Licenses Database to Merck | GenomeWeb

NEW YORK, Nov 29 – DoubleTwist has licensed its annotated human genome database package to Merck, DoubleTwist announced Wednesday.

The two-year license agreement covers the database and software for visualizing and interpreting the gene information, which Merck and seven affiliated companies plan to use in drug discovery. Merck had previously used DoubleTwist’s bioinformatics software.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.